Introduction {#s1}
============

Cells use highly coordinated cascades of regulatory mechanisms to precisely define the production of specific gene products, which in turn determine development and differentiation, allow the cell to respond to the stressful environment or to adapt to new food sources. Sophisticated programs of gene expression integrate activities from multiple factors acting at different steps along the gene expression pathway. Each and every step of this pathway can be modulated, and many factors or protein complexes act at single steps, and in less frequent cases act at a couple of different steps. However, only one factor has been connected to most steps of the gene expression pathway, and this is the Ccr4-Not complex, which has recently been reviewed quite extensively (Collart and Timmers, [@B15]; Collart and Panasenko, [@B11]; Doidge et al., [@B19]; Miller and Reese, [@B31]; Collart, [@B9]; Collart et al., [@B12]; Panepinto et al., [@B40]; Reese, [@B41]; Wahle and Winkler, [@B53]; Winkler and Balacco, [@B55]; Chapat and Corbo, [@B6]; Inada and Makino, [@B26]; Panasenko, [@B37]; Shirai et al., [@B44]; Temme et al., [@B47]; Villanyi and Collart, [@B51]; Collart, [@B10]).

Ccr4-Not was first discovered in budding yeast (Denis, [@B18]; Collart and Struhl, [@B13], [@B14]; Bai et al., [@B4]; Chen et al., [@B7]) where it is composed of 9 subunits, the Not1-Not5 proteins, Ccr4, and 3 Ccr4-associated factors, Caf1, Caf40, and Caf130. All of these subunits have orthologs in metazoans with the exception of Caf130. Metazoans have 2 orthologs for Caf1 called CNOT7 and CNOT8, 2 orthologs for Ccr4 called CNOT6 and CNOT6L and carry CNOT3 as a functional homolog of both Not5 and Not3, the products of a gene duplication event in budding yeast. Subunits with no yeast ortholog such as CNOT10 and CNOT11 are present in the metazoan Ccr4-Not complex (Albert et al., [@B2]). The metazoan ortholog of yeast Not4 is not a stable subunit of the metazoan Ccr4-Not complex but it does functionally complement the deletion of yeast Not4 (Albert et al., [@B2]; Bhaskar et al., [@B5]).

Multiple activities of the Ccr4-Not complex {#s2}
===========================================

Two different enzymatic activities are associated with the Ccr4-Not complex: deadenylation and ubiquitination. Ccr4 and Caf1 mediate deadenylation (Tucker et al., [@B49], [@B48]), the first and rate-limiting step for mRNA degradation in eukaryotes, while Not4, a RING E3 ligase, mediates ubiquitination (Albert et al., [@B1]). It poly-ubiquitinates and destabilizes some substrates (Cooper et al., [@B16]; Gronholm et al., [@B22]; Gulshan et al., [@B23]) and mono-ubiquitinates others without any consequence for their stability (Panasenko et al., [@B39]; Panasenko and Collart, [@B38]). Other non-enzymatic activities of the Ccr4-Not complex have been reported. For instance Not2, Not3 and Not5 are thought to promote decapping by interaction with the Pat1 protein (Maillet and Collart, [@B29]; Chen et al., [@B8]; Mathys et al., [@B30]; Rouya et al., [@B42]; Nishimura et al., [@B34]; Ozgur et al., [@B36]; Alhusaini and Coller, [@B3]). In contrast to these negative functions in expression of the genome, the Ccr4-Not complex also plays positive roles. For instance yeast Not5 promotes co-translational assembly of RNA Polymerase II (RNAPII) and SAGA, a function that correlates with the association of Not1 to relevant mRNAs (Villanyi et al., [@B52]; Kassem et al., [@B27]). Moreover, the Ccr4-Not complex can bind transcription elongation complexes and promote elongation of a backtracked RNAPII (Kruk et al., [@B28]). Recently an essential positive role of Not5 for production of the translation machine was uncovered. It is mediated by binding of Not1 to ribosomal mRNAs during their production in the nucleus (imprinting) (Gupta et al., [@B24]). Indeed, ribosomal protein mRNAs are enriched within the pool of mRNAs that can be immunopecipitated with Not1. The binding of Not1 to this category of mRNAs requires Not5 and negatively correlates with the level of these mRNAs in total extracts, but positively with their level in polysome fractions, with production of new ribosomal proteins and with global cellular translation levels. The fact that Not5 is needed in the nucleus to promote this Not1 binding to ribosomal mRNAs, and that Not1 binds to intronic sequences, indicated that Not1 was binding to newly produced mRNAs, hence the term "imprinting" (Gupta et al., [@B24]).

*In vivo* the deadenylase is functional when tethered to target mRNAs with the Not1 scaffold (reviewed in Collart, [@B10]). In contrast ubiquitination by Not4 does not always require its association with Not1 (reviewed in Collart, [@B9]). Tethering of the Not1 scaffold to mRNAs can also repress translation in a manner that is independent of any enzymatic activity of the complex. This is thought to occur via the interaction of the complex with proteins such as the eIF4E-binding proteins or the DDX6 RNA helicase (called Dhh1 in budding yeast).

It is intriguing that tethering of the Ccr4-Not machinery to mRNAs can promote translation and co-translational events (Villanyi et al., [@B52]; Gupta et al., [@B24]; Kassem et al., [@B27]) or promote mRNA silencing and degradation (Finoux and Seraphin, [@B20]). These opposite outcomes might be determined by the cellular compartment, in which Not1 initially binds mRNAs. Indeed it could be that the global architecture of the Ccr4-Not complex in the nucleus and the cytoplasm is different. Tethering of Not5 out of the yeast nucleus does not lead to co-depletion of nuclear Not1, supporting the idea that different Not1 complexes exist (Gupta et al., [@B24]). However, this issue still needs to be clarified and the role of the Not subunits in particular, associated with both repression and activation of gene expression, needs to be better defined.

Ribosome mutants and *NOT* mutants are similarly resistant to histidine starvation {#s3}
==================================================================================

To consolidate our understanding of the functions mediated by the Not proteins we repeated the genetic selection in budding yeast that led to their isolation (Collart and Struhl, [@B13]). The idea was that we should isolate new mutations in the *NOT* genes, and potentially also additional mutations defining the cellular function affected by the Not proteins. We screened for new mutants that could grow on medium lacking histidine and containing 5 mM 3-aminotriazole (AT), a competitive inhibitor of the His3 enzyme (Collart and Struhl, [@B13]). His3 is necessary for yeast cells to produce histidine, and transcription of the *HIS3* gene, like other amino acid biosynthetic genes, is under the control of the Gcn4 transcriptional activator. In wild type cells the translation of Gcn4 is regulated by the presence of upstream open reading frames (ORFs) and its production increases in response to starvation. For the selection, we used a starting strain (*MAT*a *ura3-52 trp1-*Δ*1 leu2-PET56 gal2 gcn4-*Δ*1*; Hope and Struhl, [@B25]) with a deletion of the endogenous *GCN4*, carrying a plasmid expressing a mutant Gcn4 (YCp88-Sc4363) with a truncated activation domain (Hope and Struhl, [@B25]) and expressed from the constitutive *DED1* promoter lacking uORFs (Collart and Struhl, [@B13]).

From the new recessive mutants isolated that were resistant to 5 mM AT in the growth medium, 9 strains carried mutations in *NOT1*, 2 in *NOT2*, 14 in *NOT3*, and 2 in *NOT4*. The mutations isolated in *NOT5* have been described (Oberholzer and Collart, [@B35]). Fifteen other recessive mutants had slow growth or temperature sensitive phenotypes that co-segregated with AT-resistance. Surprisingly they defined 15 different complementation groups. We isolated clones complementing the mutations for 6 of these and sequenced the clone ends to identify the genomic fragments. Each clone carried either a ribosomal protein gene or a gene important for ribosome biogenesis. To determine whether these mutants were defective in ribosome biogenesis, we analyzed the polysome profiles of the 6 mutants by fractionation of total cellular extracts on a sucrose gradient. All 6 had defective polysome profiles, even at the permissive temperature (data not shown). In particular shoulders indicative of the presence of half-mers were visible in all mutant profiles (see below). This indicated that ribosomes were altered, and consistently, mutations were identified for each mutant in the ribosome-related gene. Sub-clones carrying these genes, but not sub-clones lacking these genes, complemented the mutant phenotypes (Table [1](#T1){ref-type="table"}).

###### 

**List of strains and mutations isolated in the selection for AT-resistance**.

  **Strain**   **Gene**   **Protein function**                               **Mutation**   **Codon**   **mutation**
  ------------ ---------- -------------------------------------------------- -------------- ----------- ------------------------
  You95        *RPL33A*   Ribosomal                                          A553T          10          Nonsense
  You69        *FHL1*     Transcription factor for ribosomal protein genes   G1993Δ         665         Frameshift Stop at 674
  You90        *RIX1*     35S processing                                     C295T          99          Nonsense
  You101       *TSR4*     20S processing                                     C684A          228         Nonsense
  You61        *RPL28*    Ribosomal                                          G681T          57          G to V
  You114       *RPL10*    Ribosomal                                          G481T          161         G to V

To confirm that the identified mutations were responsible for AT-resistance we focused on *RPL10*, integrated a *URA3* marker gene at the *RPL10* locus and confirmed by crosses and tetrad dissection that it co-segregated with the mutant phenotype. We also recovered the mutant gene on a plasmid and confirmed that it could not complement the temperature sensitive growth phenotype. Hence, mutations in genes that impair ribosome biogenesis and decrease global translation, like mutations in the *NOT* genes, lead to resistance to histidine starvation.

Specific Not1 binding responds to decreased protein synthesis {#s4}
=============================================================

*HIS3* mRNA is increased in *not* mutants (Collart and Struhl, [@B13], [@B14]; Oberholzer and Collart, [@B35]) and we observed a similar increase in the *rpl10* mutant (data not shown). This most likely contributes to AT-resistance, possibly together with an increase in free amino acids due to reduced translation. These findings indicate that defective or reduced protein synthesis, as observed in *not* mutants or in ribosome-related mutants, is connected, possibly by the means of a cellular signal, to a relative increase in the transcript levels of an amino acid biosynthesis gene, namely *HIS3*. This raises the question of what the nature of the signal is. This signal cannot be the well-established eIF2α phosphorylation and translational up-regulation of Gcn4, known to respond to amino acid starvation, since the strain used in our selection expresses a Gcn4 derivative without uORFs.

We considered the possibility that the Not proteins themselves were part of the signaling pathway, since amino acid biosynthesis gene products are amongst the most up-regulated newly produced proteins in *not5*Δ (Gupta et al., [@B24]). Moreover, Not1 is significantly less associated with *HIS3* mRNA in *not5*Δ, and *HIS3* mRNA levels increase in total extracts and in polysomes (Gupta et al., [@B24]). To test this idea, we chose to compare 2 isogenic strains that had as only difference that they expressed a randomly chosen ribosomal protein gene at different levels. We prepared 2 *rpl13b*Δ stains containing plasmids expressing Rpl13b at different levels. One plasmid carried the endogenous *RPL13B* gene (promoter, intron, and terminator: PIT), and one plasmid contained the *RPL13B* promoter, open reading frame (ORF), and the heterologous *CYC1* terminator (POC). It also lacked an intron (constructs depicted on Figure [1A](#F1){ref-type="fig"}). Cells expressing PIT had higher levels of polysomes compared to POC, but the polysomes had shoulders indicative of the presence of ribosome half-mers and ribosome biogenesis defects (Figure [1B](#F1){ref-type="fig"}). Indeed, in a normal polysome profile the identified peaks indicate one extra ribosome per mRNA (dimer, trimer, tetramer...). Half-mers instead indicate an unequal number of 40S and 60S ribosomal subunits on the mRNA. Expression of *RPL13B* from PIT was lower than from POC (Figure [1C](#F1){ref-type="fig"}, left panel). This different expression of Rpl13b induced differences in relative expression of other cellular mRNAs such as other ribosomal mRNAs (e.g., *RPS22A)* or *HIS3* (Figure [1C](#F1){ref-type="fig"}, middle and right panels). This correlated with changes in relative binding of Not1 to those mRNAs in the 2 strains (Figure [1D](#F1){ref-type="fig"}) and in relative presence of those mRNAs in monosomes and polysomes (Figure [1E](#F1){ref-type="fig"}). *NIP1* mRNA, whose association with Not1 does not change with different expression of ribosomal mRNAs (Gupta et al., [@B24]), was used for normalization.

![**(A)** *RPL13B* constructs. Similarly to the majority of yeast RP genes with introns, in the case of *RPL13B* the entire ORF is encoded in the 2nd exon except for a methionine which is encoded in the 1st exon. Construct "PIT" contains all the endogenous elements of the *RPL13B* gene. The intron is removed and the terminator is changed to a *CYC1* terminator in "POC." **(B)** Extracts from cells expressing PIT or POC were separated on a sucrose gradient to follow the polysome profiles. The arrow points to a shoulder on the disome peak. **(C,D)** Levels of the indicated mRNAs were measured in total extracts **(C)** or in Not1 immunoprecipitates **(D)**. **(E)** Levels of the indicated mRNAs were measured in the monosome (m) and polysome (p) fractions as previously described (Gupta et al., [@B24]). The specific mRNAs measured are *RPL13B, RPS22A*, and *HIS3* as indicated, and normalization was to the *NIP1* mRNA levels.](fgene-08-00061-g0001){#F1}

Hence changes in ribosome production lead to modification of Not1 binding to *HIS3* and ribosomal mRNAs, and to changes in relative translation of those mRNAs.

Resistance to starvation resulting from ribosome or Not protein mutations could explain their frequent occurrence in cancer {#s5}
===========================================================================================================================

This study reveals that mutations in yeast ribosomal genes or ribosome biogenesis genes, like mutations in the *NOT* genes that affect global translation (Gupta et al., [@B24]), lead to increased resistance to histidine starvation. In metazoan cells, altering Not function or disrupting the translation machine, can also have similar phenotypes. Indeed, mutations in CNOT3, the ortholog of Not5, or in the RPL5 and RPL10 ribosomal proteins, are associated with adult T-cell acute lymphoblastic leukemia (T-ALL) (De Keersmaecker et al., [@B17]). T-ALL is an aggressive malignancy caused by the accumulation of genomic lesions leading to altered gene dosage. RPL5 and RPL10 occupy neighboring positions in the 60S subunit of the ribosomes, next to the central protuberance, which is in close vicinity to both the P, A, and E sites of the ribosomes. Around 8% of pediatric T-ALL patients harbor an Arg98Ser mutation in RPL10, which was shown to reduce translation fidelity (Sulima et al., [@B45]). RPL22 on the other hand forms the narrowest constriction of the ribosomal exit tunnel (Nakatogawa and Ito, [@B33]). Mutations in RPL22 are believed to alter protein synthesis efficacy. CNOT3 in T-ALL patients frequently carries missense mutations in Arg57 that affects splicing and reduces CNOT3 levels (De Keersmaecker et al., [@B17]). According to our work in yeast this should lead to reduced global translation and also to defects in co-translational complex assembly and consequently to elevated protein aggregation (Panasenko and Collart, [@B38]; Villanyi et al., [@B52]; Gupta et al., [@B24]; Kassem et al., [@B27]). Thus it appears that alteration of the process of translation in cancer cells can ensure their survival.

Numerous reports have described the presence of frequent mutations in ribosome subunits in tumor cells and different mechanisms have been considered to explain how RP mutations contribute to tumorigenesis or tumor maintenance (reviewed in Ruggero, [@B43]; Wang et al., [@B54]; Goudarzi and Lindstrom, [@B21]). Three main pathways have generally been considered: global suppression of protein synthesis, specific suppression of protein synthesis or finally extra-ribosomal functions. Our current observations suggest that relative up-regulation of amino acid biosynthesis genes resulting from global alteration of the translation process might contribute to sustain growth of the tumor cells. Since Not5 in particular appears to be involved in the regulatory loop linking translation to amino acid biosynthesis, the ortholog CNOT3 may have a tumor suppressor function. This is certainly compatible with the fact that mutations in CNOT3 have been identified in many tumors (Collart et al., [@B12]).

It is important to note that an impact of CNOT3 on amino acid biosynthesis is unlikely to be the only mechanism, by which a mutation of CNOT3 in tumor cells might contribute to tumor survival. This protein has very broad cellular functions and it has for instance been described as a modifier of gene expression that leads to incomplete penetrance of PRFP31 mutations in retinitis pigmentosa (Venturini et al., [@B50]). We have reported that in yeast Not1 and Not5 are important for gene expression homeostasis, buffering between transcription, translation and mRNA decay to maintain steady state protein levels (Villanyi and Collart, [@B51]). The deletion of Not5 leads to very slow growth of yeast cells, and the deletion of both alleles of CNOT3 is embryonic lethal in mice. Moreover, CNOT3^+/−^ mice have many disturbed physiological functions (Morita et al., [@B32]; Shirai et al., [@B44]) indicating a very essential function of this protein (reviewed in Collart et al., [@B12]). It could be that the lower dose of *CNOT3* in T-ALL cells does not disturb the major gene expression buffering function of CNOT3, but does have an impact on protein folding and complex assembly. The same could be true for the frequent *RPL5, RPL10*, and *RPL22* mutations: affecting translation fidelity or efficacy has obvious dosage compensatory effects, as improperly assembled or folded proteins are likely to be non-functional, and prone to degradation or aggregation. In this context it is interesting to note that it has been reported that null mutants of specific Ccr4-Not subunits reduce the viability of aneuploid yeast cells (Tange et al., [@B46]). There may be a very fine balance between the impairment of Ccr4-Not function that can ensure survival of tumor cells with genomic lesions, or instead more severe *ccr4-not* mutations that will be toxic.

Conclusion {#s6}
==========

The Ccr4-Not complex acts at all stages of the gene expression pathway, and has both positive and negative effects on gene expression. Clarifying which contribution of Ccr4-Not regulation is important or lost in specific biological contexts is a real challenge. Work *in vivo* cannot easily distinguish direct from indirect effects, whereas studies *in vitro* define what the complex can do, but not how and when this is relevant *in vivo*. Here we point out that perturbation of translation is positively affecting amino acid biosynthesis that can facilitate cancer cell survival. We suggest that Not5 might not only regulate production of the translation machinery but also participate in the cross-talk between translation and amino acid production. Finally, we put forward the idea that impaired translation might contribute to dosage compensation via production of non-functional proteins. As the story of Ccr4-Not unfolds, it is clear that its understanding requires an open mind.
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